Do Options Traders Know Something About RxSight Stock We Don't?

RxSight (RXST) options are exhibiting high implied volatility, specifically the Jun 20, 2025 $27.50 Call, suggesting expectations of a significant price movement. Despite this, analysts have recently lowered earnings estimates, resulting in a Zacks Rank #4 (Sell) rating, potentially creating an opportunity for options traders to sell premium, anticipating the stock will not move as much as the volatility suggests.

Analysis

RxSight, Inc. (RXST) is exhibiting significant market attention, primarily driven by heightened implied volatility in its options, specifically the Jun 20, 2025 $27.50 Call. This suggests investors are anticipating a substantial price movement in either direction for the underlying stock, potentially linked to an upcoming event or catalyst. However, this market expectation contrasts sharply with the company's current fundamental outlook. RxSight holds a Zacks Rank #4 (Sell), and its earnings prospects for the current quarter have weakened; over the last 30 days, two analysts have revised their earnings estimates downward, with no upward revisions. Consequently, the Zacks Consensus Estimate for current quarter earnings has declined from 1 cent per share to breakeven. While RxSight operates within the Medical - Instruments industry, which ranks in the Top 37% of Zacks Industry Ranks, the company-specific analyst sentiment appears bearish, creating a dichotomy between options market expectations and fundamental analyst ratings.

Key Decisions for Investors

• Investors should exercise caution with RxSight's equity, considering the Zacks Rank #4 (Sell) and recent negative revisions to earnings estimates, despite the options market pricing in a significant move.
• Traders with an appropriate risk appetite might explore options strategies that capitalize on high implied volatility, such as selling premium, if their thesis aligns with the stock not moving as dramatically as the volatility suggests, or if they can accurately predict the direction of the anticipated move.
• Closely monitor RxSight for any specific company announcements or industry developments that could trigger the large price swing implied by options market activity, and be prepared for increased volatility.